MEK Inhibitor News and Research

RSS
Merck's Keytruda gets FDA approval for treatment of malignant melanoma

Merck's Keytruda gets FDA approval for treatment of malignant melanoma

Researchers develop new way to identify potential therapeutic targets for drug resistant melanoma

Researchers develop new way to identify potential therapeutic targets for drug resistant melanoma

Clinical trial shows that selumetinib drug can delay progression of metastatic uveal melanoma

Clinical trial shows that selumetinib drug can delay progression of metastatic uveal melanoma

Eventual drug resistance prevents long-term cure in most patients with metastatic melanoma

Eventual drug resistance prevents long-term cure in most patients with metastatic melanoma

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

New data presented at EADO on investigational MEK inhibitor in combination with BRAF inhibitor for metastatic melanoma

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

Exelixis presents final Phase 1b data on investigational MEK-BRAF inhibitor combination therapy for metastatic melanoma

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

Virginia researchers develop new combination therapy that could potentially treat multiple myeloma

Tau Therapeutics presents data of T-type calcium channel inhibitors in treatment of pancreatic cancer

Tau Therapeutics presents data of T-type calcium channel inhibitors in treatment of pancreatic cancer

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Study describes new tack in treatment of lung adenocarcinomas

Study describes new tack in treatment of lung adenocarcinomas

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Researchers identify two novel BRAF fusions in melanomas

Researchers identify two novel BRAF fusions in melanomas

Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

New hope for patients whose melanoma has metastasised to the brain

New hope for patients whose melanoma has metastasised to the brain

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

AstraZeneca begins selumetinib Phase 3 clinical trial in NSCLC patients

AstraZeneca begins selumetinib Phase 3 clinical trial in NSCLC patients

Study compares spectrum of cancer-related gene mutations in two common types of cervical cancer

Study compares spectrum of cancer-related gene mutations in two common types of cervical cancer

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Array BioPharma achieves milestone for initiation of MEK162 Phase 3 trial in patients with LGSOC

Array BioPharma achieves milestone for initiation of MEK162 Phase 3 trial in patients with LGSOC